{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Her House: Built for Women's Health","title":"Why We Can't Stop Talking About Women's Health","html":"","width":"100%","height":180,"duration":140,"description":"Her House: Built for Women's Health is all about engaging and encouraging women to be proactive advocates in their healthcare experience. We strive to celebrate leaders and care providers who are building solutions for the betterment of women's health. \nDid you know?\nWomen weren’t required to be included in U.S. clinical trials until 1993.\nThat means decades of medical research was built primarily on male biology.\nWomen’s bodies have been underrepresented in basic research.\nIn animal studies, male mice were often the default — despite sex differences that could affect outcomes.\n \nSex-specific analysis and dosing has historically been rare in drug approvals.\nEven though women metabolize many medications differently than men.\nThankfully,\nFunding for women’s health research has nearly doubled in the past decade.\nMajor public and private initiatives are prioritizing sex-based research like never before.\nThe FDA is increasingly mandating sex-based data analysis in clinical trials.\nMore therapies are now being evaluated and approved with women’s unique biology in mind.\nFemtech is one of the fastest-growing health sectors.\nStartups are driving innovation in menstrual health, fertility, menopause, and chronic conditions affecting women.\nRead the Women's Health Access Matters Report","thumbnail_url":"https://img.transistorcdn.com/oPi2hu6Sl0cKK7tzZvW5Xsft2hXx9PvEjbPiNgImW1s/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yODhi/ZWQ1MjY1NGY4Nzc4/YmMzOTdmNTE4Zjk2/YjIyYi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}